Next Article in Journal
Correction: Awad et al. Repurposing Potential of the Antiparasitic Agent Ivermectin for the Treatment and/or Prophylaxis of COVID-19. Pharmaceuticals 2022, 15, 1068
Next Article in Special Issue
Study on the Therapeutic Effects and Mechanisms of Gintonin in Irritable Bowel Syndrome and Its Relationship with TRPV1, TRPV4, and NaV1.5
Previous Article in Journal
Haloperidol for Pain Management: A Narrative Review
Previous Article in Special Issue
TRPV1 Channels in the Central Nervous System as Drug Targets
 
 
Article

Article Versions Notes

Pharmaceuticals 2024, 17(8), 1098; https://doi.org/10.3390/ph17081098
Action Date Notes Link
article xml file uploaded 21 August 2024 14:32 CEST Original file -
article xml uploaded. 21 August 2024 14:32 CEST Update -
article pdf uploaded. 21 August 2024 14:32 CEST Version of Record -
article html file updated 21 August 2024 14:34 CEST Original file -
article xml file uploaded 21 August 2024 16:03 CEST Update -
article xml uploaded. 21 August 2024 16:03 CEST Update -
article pdf uploaded. 21 August 2024 16:03 CEST Updated version of record https://www.mdpi.com/1424-8247/17/8/1098/pdf
article html file updated 21 August 2024 16:04 CEST Update -
article xml file uploaded 27 August 2024 10:42 CEST Update -
article xml uploaded. 27 August 2024 10:42 CEST Update https://www.mdpi.com/1424-8247/17/8/1098/xml
article html file updated 27 August 2024 10:44 CEST Update https://www.mdpi.com/1424-8247/17/8/1098/html
Back to TopTop